Jonathan Fox
President at EIDOS THERAPEUTICS, INC.
Net worth: 198 032 $ as of 2024-03-30
Profile
Jonathan C. Fox occupies the position of President & Chief Medical Officer at Eidos Therapeutics, Inc. In his past career he was Chief Medical Officer at MyoKardia, Inc., Senior Director-Clinical Cardiovascular Research at Merck & Co., Inc., Vice President-Clinical Development at AstraZeneca LP, Director-Clinical Pharmacology at GlaxoSmithKline LLC, Clinical Professor at the University of Pennsylvania, Consultant at The University of California, San Francisco and Consulting Professor at Stanford University. Jonathan C. Fox received a doctorate and an undergraduate degree from The University of Chicago.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-12-25 | 10,857 ( 0.01% ) | 198 032 $ | 2024-03-30 |
Jonathan Fox active positions
Companies | Position | Start |
---|---|---|
EIDOS THERAPEUTICS, INC. | President | 2016-09-30 |
EDGEWISE THERAPEUTICS, INC. | Director/Board Member | 2023-03-01 |
BRIDGEBIO PHARMA, INC. | President | - |
ML Bio Solutions, Inc. | Director/Board Member | - |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Director/Board Member | - |
Former positions of Jonathan Fox
Companies | Position | End |
---|---|---|
MYOKARDIA, INC. | Chief Tech/Sci/R&D Officer | 2016-09-29 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 2011-12-31 |
Stanford University | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Jonathan Fox
The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Private companies | 7 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Edgewise Therapeutics, Inc. | |
ML Bio Solutions, Inc. |
- Stock Market
- Insiders
- Jonathan Fox